Bendamustine as an alkylating agent used for the treatment of chronic lymphocytic leukemia (CLL) and lymphoma. It is currently under investigation for treatment of sarcoma.
Bendamustine 100 mg
Bendamustine is used in the treatment of chronic lymphocytic leukemia (type of cancer that starts from white blood cells in the bone marrow), non-Hodgkin's lymphomas (cancer that originates in lymphatic system, the disease-fighting network spread throughout your body) after failed treatment with rituximab and multiple myeloma (cancer that forms in plasma cell) in combination with prednisone.
Bendamustine belongs to class of drugs called alkylating agents. It works by destroying the DNA, thus killing the existing cancer cells and also preventing the growth and spread of new cancer cells.
Bleeding, Fatigue, Weakness or breathlessness due to lack of oxygen in blood, Nausea, Pale skin, Dehydration, Decreased hemoglobin level, Allergic skin rash, Disturbed lung function, Chills, Vomiting, Skin changes, Redness, Low counts of neutrophils, Infections, Lungs and gut, Peeling and bleeding from the inner lining of mouth, Pain, Disturbed heart rhythms, Increased bile pigment, Decreased white blood cells, Disturbed metabolism, Constipation, Loss of appetite, Diarrhea, Low blood potassium level, Low or high blood pressure, Lack of sleep, Fever, A rise in liver enzymes, Hair loss, Sore mouth, Missed periods, Increased blood level of creatinine and/or urea, Low counts of platelets